Home - JDNPPA

Beyond Antihistamines: New Urticaria Treatments Target Mast Cells

Advertisement

Guselkumab Scores U.S. FDA Nod for Kids With Psoriasis and PsA

September 29, 2025

Access Update: BMS Offers Deep Discounts on Deucravacitinib (Sotyktu)

September 28, 2025

JDNPPA Expert Reaction: U.S. FDA Approves Ruxolitinib Cream for Young Kids With AD

September 22, 2025

Taking a Deep Dive Into New Real-world Safety Data on Upadacitinib (Rinvoq, AbbVie) in AD With Dr. Christopher Bunick

September 20, 2025

Advertisement

Advertisement

Latest Issue

Advertisement

Latest Supplements

Upcoming Conferences

Advertisement

Advertisement

Digital Edition Archive